Scarica l'app Stockscreener
20.02
0.94%
-0.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ZLAB Giù?
Forum
Previsione
Precedente Chiudi:
$20.21
Aprire:
$19.66
Volume 24 ore:
631.52K
Relative Volume:
0.81
Capitalizzazione di mercato:
$2.24B
Reddito:
$418.33M
Utile/perdita netta:
$-252.07M
Rapporto P/E:
-8.3417
EPS:
-2.4
Flusso di cassa netto:
$-238.84M
1 W Prestazione:
-7.95%
1M Prestazione:
-31.32%
6M Prestazione:
-38.57%
1 anno Prestazione:
-22.10%
Intervallo 1D:
$19.51
$20.17
Intervallo di 1 settimana:
$19.51
$21.39
Portata 52W:
$19.51
$44.34
Zai Lab Limited Adr Stock (ZLAB) Company Profile
Nome
Zai Lab Limited Adr
Settore
Industria
Telefono
862161632588
Indirizzo
899 HALEI ROAD, SHANGHAI
Confronta ZLAB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
20.02 | 2.24B | 418.33M | -252.07M | -238.84M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-25 | Ripresa | Jefferies | Buy |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2025-03-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-14 | Iniziato | Morgan Stanley | Overweight |
| 2023-08-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-01-21 | Iniziato | Macquarie | Outperform |
| 2021-10-12 | Iniziato | Bernstein | Mkt Perform |
| 2020-04-28 | Iniziato | Goldman | Buy |
| 2020-04-15 | Iniziato | Guggenheim | Buy |
| 2019-07-12 | Iniziato | BofA/Merrill | Buy |
| 2019-07-05 | Iniziato | Macquarie | Outperform |
| 2019-01-29 | Iniziato | Credit Suisse | Outperform |
| 2018-11-21 | Iniziato | Jefferies | Buy |
| 2018-06-21 | Ripresa | Leerink Partners | Outperform |
| 2018-02-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2017-10-16 | Iniziato | JP Morgan | Neutral |
| 2017-10-16 | Iniziato | Leerink Partners | Outperform |
Mostra tutto
Zai Lab Limited Adr Borsa (ZLAB) Ultime notizie
Can Zai Lab Limited (1ZLB) stock test all time highsQuarterly Portfolio Review & High Conviction Buy Zone Alerts - newser.com
Zai Lab Limited (NASDAQ:ZLAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know - simplywall.st
Analyst Forecasts Just Became More Bearish On Zai Lab Limited (NASDAQ:ZLAB) - simplywall.st
There is no doubt that Zai Lab Limited ADR (ZLAB) ticks all the boxes. - Setenews
You might want to take a look at Qualcomm, Inc (QCOM) now - Setenews
symbol__ Stock Quote Price and Forecast - CNN
Stocks of Super Group (SGHC) Limited (SGHC) are poised to climb above their peers - setenews.com
Zai Lab (NASDAQ:ZLAB) Sets New 1-Year Low After Earnings Miss - Defense World
Zai Lab Ltd (ZLAB) Q3 2025 Earnings: EPS Loss of $0.03 Beats Est - GuruFocus
Revenues Working Against Zai Lab Limited's (NASDAQ:ZLAB) Share Price Following 26% Dive - simplywall.st
Why Zai Lab Limited (1ZLB) stock appeals to dividend investors2025 Bull vs Bear & Real-Time Buy Zone Alerts - Fundação Cultural do Pará
Brokerages Set Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Price Target at $56.35 - Defense World
Keeping an Eye on Nine Energy Service Inc (NINE) After Insider Trading Activity - knoxdaily.com
Zai Lab (NasdaqGM:ZLAB): Evaluating Valuation Following Promising Trial Results and Phase 3 Progress - Sahm
EBITDA per share of Zai Lab Ltd. Sponsored ADR – GETTEX:1ZL - TradingView
Did Zai Lab’s (ZLAB) Promising Zoci Trial Results Just Shift Its Investment Narrative? - Sahm
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Zai Lab (ZLAB) to Release Quarterly Earnings on Thursday - MarketBeat
Zai Lab Announces Participation in Investor Conferences in November and December 2025 - The Globe and Mail
Zai Lab Announces Participation in Investor Conferences in September 2025 - Markets Financial Content
Zai Lab (NASDAQ:ZLAB) Stock Price Down 4.6%Time to Sell? - MarketBeat
Zai Lab Announces Updated Phase 1 Data for Zocilurtatug Pelitecan (formerly ZL-1310), Demonstrating Potential as a First-in-Class/Best-in-Class DLL3-Targeted ADC for Small Cell Lung Cancer, and Initiation of Global Phase 3 Registrational Study - Business Wire
Q3 Earnings Estimate for Zai Lab Issued By Leerink Partnrs - MarketBeat
Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last? - MSN
Zai Lab Secures RMB300 Million Debt Facility - The Globe and Mail
[8-K] Zai Lab Ltd Reports Material Event | ZLAB SEC FilingForm 8-K - Stock Titan
Zai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November 6, 2025 - The Globe and Mail
Zai Lab (NASDAQ:ZLAB) Trading Down 6.2%Here's What Happened - MarketBeat
Late‑breaking Phase 1 data for Zoci: Zai Lab to present DLL3‑targeted ADC results at AACR Oct 24, 2025 - Stock Titan
Operating cash flow per share of Zai Lab Ltd. Sponsored ADR – BER:1ZL - TradingView
Zai Lab Announces Oral Presentation of Updated Data from Global Phase 1 Trial of Zocilurtatug Pelitecan (ZL-1310), a Potential First-in-Class DLL3-Targeted ADC, at 2025 AACR-NCI-EORTC Conference - Business Wire
Trip.com Group LimitedAmerican Depositary Shares (NQ: - FinancialContent
Is Zai Lab's Valuation Justified as Revenue Growth Lags the Biotech Industry (ZLAB)? - Sahm
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
ETFs Investing in Zai Lab Ltd. Sponsored ADR Stocks - TradingView
Zai Lab Limited Announces Equity Incentive Grants to Employees - MSN
Zai Lab (NASDAQ:ZLAB) Shares Gap UpStill a Buy? - MarketBeat
Zai Lab Limited Depositary Receipt Stock Analysis and ForecastStochastic Oscillator Alerts & High Profit Trading Signals - Early Times
Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR) and Zai Lab (ZLAB) - The Globe and Mail
How robust is Anheuser Busch Inbev SA Sponsored ADR stock financial position2025 Volume Leaders & Free High Return Stock Watch Alerts - newser.com
Zai Lab Limited Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsZLAB - ACCESS Newswire
Acadian Asset Management LLC Buys New Shares in Zai Lab Limited Unsponsored ADR $ZLAB - MarketBeat
Levi & Korsinsky Reminds Shareholders of an Investigation into Zai Lab Limited (ZLAB) Regarding Potential Securities Fraud Allegations - ACCESS Newswire
Lost Money on Zai Lab Limited (ZLAB)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives $56.35 Consensus Price Target from Analysts - MarketBeat
Shareholder Rights Advocates at Levi & Korsinsky Investigate Zai Lab Limited (ZLAB) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Insider Buying: Zai Lab (NASDAQ:ZLAB) Insider Purchases 10,000 Shares of Stock - MarketBeat
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives $56.35 Average PT from Brokerages - Defense World
Zai Lab Limited Adr Azioni (ZLAB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):